122 related articles for article (PubMed ID: 16113979)
1. RSC-SCI--tenth medicinal chemistry symposium. 5-8 September 1999, Churchill College, Cambridge, UK.
Cliffe IA; Bebbington D; Gillespie RJ; Knutsen LJ
IDrugs; 1999 Nov; 2(11):1122-5. PubMed ID: 16113979
[TBL] [Abstract][Full Text] [Related]
2. Successes and pitfalls of medical chemistry programs.
Norman P
Drug News Perspect; 2001 Nov; 14(9):551-67. PubMed ID: 12806443
[TBL] [Abstract][Full Text] [Related]
3. Medicinal chemistry--16th international symposium. 18-22 September 2000, Bologna, Italy.
Bently J; Cliffe IA; Knutsen LJ; Monck N
IDrugs; 2000 Dec; 3(12):1457-86. PubMed ID: 16037858
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. The Medicinal and Bioorganic Chemistry Foundation--third winter conference. 23-29 January 1999, Steamboat Springs, CO, USA.
Mitscher LA
IDrugs; 1999 Apr; 2(4):289-94. PubMed ID: 16158345
[TBL] [Abstract][Full Text] [Related]
6. Medicinal Chemistry in eastern England--tenth symposium. 22 April 1999, University of Hertfordshire, Hatfield, UK.
Norman P
IDrugs; 1999 Jul; 2(7):659-63. PubMed ID: 16127635
[TBL] [Abstract][Full Text] [Related]
7. Medicinal Chemistry--XVth EFMC International Symposium. New technologies in drug discovery. 6-10 September 1998, Edinburgh, Scotland, UK.
Buckle DR
IDrugs; 1998 Dec; 1(8):860-2. PubMed ID: 16196472
[TBL] [Abstract][Full Text] [Related]
8. Protease Inhibition: Design, Technology & Opportunities--First RSC/SCI Symposium on Protease Inhibition.18-19 May 1998, London, UK.
Buckle DR
IDrugs; 1998 Jun; 1(2):185-8. PubMed ID: 18465527
[TBL] [Abstract][Full Text] [Related]
9. Medicinal Chemistry--13th RSC-SCI Symposium.
Herrick V
IDrugs; 2005 Nov; 8(11):901-3. PubMed ID: 16254781
[No Abstract] [Full Text] [Related]
10. Partnership between small biotech and big pharma.
Wiederrecht GJ; Hill RG; Beer MS
IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
[TBL] [Abstract][Full Text] [Related]
11. Aspects of successful drug discovery and development.
Pauwels R
Antiviral Res; 2006 Sep; 71(2-3):77-89. PubMed ID: 16828174
[TBL] [Abstract][Full Text] [Related]
12. RSC-SCI medicinal chemistry--11th symposium. New technologies and late-breaking science.
Norman P
IDrugs; 2001 Oct; 4(10):1124-7. PubMed ID: 15957075
[No Abstract] [Full Text] [Related]
13. Chemistry strategies in early drug discovery: an overview of recent trends.
Colombo M; Peretto I
Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762
[TBL] [Abstract][Full Text] [Related]
14. Strategies to assess the drug interaction potential in translational medicine.
Persiani S; Larger P
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):675-86. PubMed ID: 17014388
[TBL] [Abstract][Full Text] [Related]
15. When poor solubility becomes an issue: from early stage to proof of concept.
Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
[TBL] [Abstract][Full Text] [Related]
16. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
Srinivas NR
Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
[TBL] [Abstract][Full Text] [Related]
17. Society for Anti-infective Pharmacology--Ninth International Symposium. 3-4 July 1999, Birmingham, UK.
Witty D
IDrugs; 1999 Sep; 2(9):874-6. PubMed ID: 16121300
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic enzymes as therapeutic targets - Keystone Symposium. 3-8 February 2002, Keystone, CO, USA.
Creemers J
IDrugs; 2002 Mar; 5(3):216-9. PubMed ID: 15562329
[TBL] [Abstract][Full Text] [Related]
19. The role of pharmacodynamic research in the assessment and development of new antibacterial drugs.
Lister PD
Biochem Pharmacol; 2006 Mar; 71(7):1057-65. PubMed ID: 16316633
[TBL] [Abstract][Full Text] [Related]
20. The 18th European symposium on quantitative structure-activity relationships.
Tsantili-Kakoulidou A; Agrafiotis DK
Expert Opin Drug Discov; 2011 Apr; 6(4):453-6. PubMed ID: 22646021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
